Assessing the Efficacy of Methanol Extracts of Ocimum Sanctum Linn. and Ocimum Basilicum Linn. in Diabetic Neuropathy
Abstract
Background/Aim: Our nerves can be impacted by thousands of diseases and ailments, but diabetes-related neuropathy is the name given to the endocrine system issue that results in nerve damage. Herbal plants having antioxidant activity play an important role in managing diabetes and the associated complications. Ocimum sanctum and Ocimum basilicum plants have shown antihyperglycemic as well as neuroprotective activity but the effect of Ocimum sanctum and Ocimum basilicum on diabetic neuropathy (DN) has not been studied so far. So, the given manuscript was aimed to evaluate the effect of both plants by various in vitro biochemical parameters as well as in vivo studies.
Methods: The given manuscript describes the effect of methanol extracts of Ocimum sanctum and Ocimum basilicum, in DN induced Swiss albino mice of either sex weighing 25-35 g. Mice were divided into 6 groups viz control (I) receiving citrate buffer, diabetic (II) and test groups (III, IV, V, VI) receiving streptozotocin at a dose of 100 mg/kg to induce DN on 21st day followed by treatment of test groups (III, IV, V, VI) at a dose of 100 mg/kg and 200 mg/kg daily for 14 days, with Ocimum basilicum and Ocimum sanctum, respectively.
Results: The results showed that the methanol extracts of Ocimum sanctum and Ocimum basilicum gave significant change in weight variation, tail immersion test and blood glucose in comparison to diabetic control. In brain tissue homogenate measurement of oxidative stress by thiobarbituric acid reactive substance (TBARS), glutathione (GSH) and serum nitrite level, the methanol extract of both plants produced significant change when compared to diabetic control.
Conclusion: This study underscores the promising role of herbal adjuncts in addressing the complexities of diabetic neuropathy and warrants continued investigation into their clinical utility.
References
Hussain S, Habib A, Najmi AK. Anemia prevalence and its impact on health-related quality of life in Indian diabetic kidney disease patients: Evidence from a cross-sectional study. J Evid Based Med. 2019 Nov;12(4):243-52. doi: 10.1111/jebm.12367.
Hussain S, Habib A, Singh A, Akhtar M, Najmi AK. Prevalence of depression among type 2 diabetes mellitus patients in India: A meta-analysis. Psychiatry Res. 2018 Dec;270:264-73. doi: 10.1016/j.psychres.2018.09.037.
Hussain S, Jamali MC, Habib A, Hussain S, Akhtar M, Najmi AK. Diabetic kidney disease: an overview of prevalence, risk factors, and biomarkers. Clinical Epidemiology and Global Health. 2020. doi: 10.1016/j. cegh.2020.05.016.
Abbott CA, Malik RA, van Ross ER, Kulkarni J, Boulton AJ. Prevalence and characteristics of painful diabetic neuropathy in a large community-based diabetic population in the U.K. Diabetes Care. 2011 Oct;34(10):2220-4. doi: 10.2337/dc11-1108.
Boulton AJ, Gries FA, Jervell JA. Guidelines for the diagnosis and outpatient management of diabetic peripheral neuropathy. Diabet Med. 1998 Jun;15(6):508-14. doi: 10.1002/(SICI)1096-9136(199806)15:6<508::AID-DIA613>3.0.CO;2-L.
Veves A, Backonja M, Malik RA. Painful diabetic neuropathy: epidemiology, natural history, early diagnosis, and treatment options. Pain Med. 2008 Sep;9(6):660-74. doi: 10.1111/j.1526-4637.2007.00347.x.
WebMD, LLC [Internet]. Peripheral neuropathy and diabetes. [Cited: 21-Jul-2018]. Available at: http://www.webmd.com/diabetes/ peripheralneuropathyriskfactorssymptoms.
Ashok S, Ramu M, Deepa R, Mohan V. Prevalence of neuropathy in type 2 diabetic patients attending a diabetes centre in South India. J Assoc Physicians India. 2002 Apr;50:546-50. PMID: 12164406.
Karki DB, Yadava SK, Pant S, Thusa N, Dangol E, Ghimire S. Prevalence of sensory neuropathy in type 2 diabetes mellitus and its correlation with duration of disease. Kathmandu Univ Med J (KUMJ). 2016 Apr-Jun;14(54):120-4. PMID: 28166066.
Ibarra CT, Rocha Jde J, Hernández RO, Nieves RE, Leyva RJ. [Prevalence of peripheral neuropathy among primary care type 2 diabetic patients]. Rev Med Chil. 2012 Sep;140(9):1126-31. Spanish. doi: 10.4067/S0034-98872012000900004.
Khawaja N, Abu-Shennar J, Saleh M, Dahbour SS, Khader YS, Ajlouni KM. The prevalence and risk factors of peripheral neuropathy among patients with type 2 diabetes mellitus; the case of Jordan. Diabetol Metab Syndr. 2018 Feb 21;10:8. doi: 10.1186/s13098-018-0309-6.
Shera AS, Jawad F, Maqsood A, Jamal S, Azfar M, Ahmed U. Prevalence of chronic complications and associated factors in type 2 diabetes. J Pak Med Assoc. 2004 Feb;54(2):54-9. PMID: 15134204.
International Diabetes Federation. Diabetes Facts and Figures [Internet]. [Cited: 20-Jpr-2020]. Available at: https://www.idf.org/aboutdiabetes/what-is-diabetes/facts-figures.html.
Benbow SJ, Wallymahmed ME, MacFarlane IA. Diabetic peripheral neuropathy and quality of life. QJM. 1998 Nov;91(11):733-7. doi: 10.1093/qjmed/91.11.733.
Darivemula S, Nagoor K, Patan SK, Reddy NB, Deepthi CS, Chittooru CS. Prevalence and its associated determinants of diabetic peripheral neuropathy (dpn) in individuals having type-2 diabetes mellitus in rural south india. Indian J Community Med. 2019 Apr-Jun;44(2):88-91. doi: 10.4103/ijcm.IJCM_207_18.
Jayant SK, Srivastava N. Effect of Ocimum sanctum against alloxan induced diabetes and biochemical alterations in rats. Integr Obesity Diabetes 2016;2(5):1-4. doi: 10.15761/IOD.1000162.
Vinik AI, Mehrabyan A. Diabetic neuropathies. Med Clin North Am. 2004 Jul;88(4):947-99, xi. doi: 10.1016/j.mcna.2004.04.009.
Nilay D. Solanki ND, Bhavsar SK, Pandya DT. Role of phytotherapy in diabetic neuropathy and neurodegeneration: from pathogenesis to treatment. J Phytopharmacol. 2018;7(2):152-61. doi: 10.31254/phyto.2018.7209.
Boham BA, Kocipai AR. Flavanoids and condense tannins from leaves of Hawaiian Vaccinium vaticulatum and V. Calicinium. Pacific Sci. 1994;48(4):458-63.
Bonjar GHS, Nik AK, Aghighi S. Antibacterial and antifungal survey in plants used in indigenous herbal-medicine of south east regions of Iran. J Biolog Sci. 2004;4(3):405-12. doi: 10.3923/jbs.2004.405.412.
Doss A. Preliminary phytochemical screening of some Indian Medicinal Plants. Anc Sci Life. 2009 Oct;29(2):12-6. PMID: 22557345.
Rai V, Iyer U, Mani UV. Effect of Tulasi (Ocimum sanctum) leaf powder supplementation on blood sugar levels, serum lipids and tissue lipids in diabetic rats. Plant Foods Hum Nutr. 1997;50(1):9-16. doi: 10.1007/BF02436038.
Antora RA, Salleh RM. Antihyperglycemic effect of Ocimum plants: A short review. Asian Pacific J Trop Biomed. doi: 10.1016/j.apjtb.2017.07.010.
Rubab S, Hussain I, Khan BA, Unar AA, Abbas KA, Khichi ZH, et al. Biomedical description of Ocimum basilicum L. J Islamic Int Med Coll 2017;12(1):59–67.
Janick J, Simon JE. Advances in New Crops; Portland, OR, USA: Timber Press 1990; pp. 484–489.
Ch MA, Naz SB, Sharif A, Akram M, Saeed MA. Biological and pharmacological properties of the sweet basil (Ocimum basilicum). J Pharm Res Int. 2015;7(5):330–9. doi: 10.9734/BJPR/2015/16505.
Purushothaman B, Srinivasan RP, Suganthi P, Ranganathan B, Gimbun J, Shanmugam KA comprehensive review on Ocimum basilicum. J Nat Remedies 2018;18(3):71–85. doi: 10.18311/jnr/2018/21324.
Majdi C, Pereira C, Dias MI, Calhelha RC, Alves MJ, Rhourri-Frih B, et al. Phytochemical Characterization and Bioactive Properties of Cinnamon Basil (Ocimum basilicum cv. 'Cinnamon') and Lemon Basil (Ocimum×citriodorum). Antioxidants (Basel). 2020 Apr 29;9(5):369. doi: 10.3390/antiox9050369.
Duke JA, Ayensu ES. Medicinal plants of China. Michigan: Reference Publications; 1985.
Shakeri F, Hosseini M, Ghorbani A. Neuropharmacological effects of Ocimum basilicum and its constituents. Physiol Pharmacol 2019;23:70-81.
Chandrasekaran CV, Srikanth HS, Anand MS, Allan JJ, Viji MM, Amit A. Evaluation of the mutagenic potential and acute oral toxicity of standardized extract of Ocimum sanctum (OciBest™). Hum Exp Toxicol. 2013 Sep;32(9):992-1004. doi: 10.1177/0960327112472992.
Mahajan N, Rawal S, Verma M, Poddar M,Alok S. A phytopharmacological overview on Ocimum species with special emphasis on Ocimum sanctum. Biomed Prevent Nutr. 2013;3(2):185-92. doi: 10.1016/j.bionut.2012.08.002.
Pattanayak P, Behera P, Das D, Panda SK. Ocimum sanctum Linn. A reservoir plant for therapeutic applications: An overview. Pharmacogn Rev. 2010 Jan;4(7):95-105. doi: 10.4103/0973-7847.65323.
Sethi J, Sood S, Seth S, Talwar A. Evaluation of hypoglycemic and antioxidant effect of Ocimum sanctum. Indian J Clin Biochem. 2004 Jul;19(2):152-5. doi: 10.1007/BF02894276.
Suanarunsawat T, Songsak T. Anti-hyperglycemic and anti-hyperlipidemic effect of dietary supplement of white Ocimum sanctum L. before and after STZ-induced diabetes mellitus. Int J Diabetes Metab. 2005;13(1):18-23. doi: 10.1159/000497569.
Madhuri, S. Studies on oestrogen induced uterine and ovarian carcinogenesis and effect of ProImmu in rats. Ph.D. thesis, Rani Durgavati, Vishwa Vidyalaya, Jabalpur, MP, India: 2008.
Madhuri S, Govind P. Effect of ProImmu, a herbal drug on estrogen caused uterine and ovarian cytotoxicity. Biomed. 2010;5(1):57-62.
Bihari CG, Manaswini B, Panda SKSP, Tripathy SKST. Phytochemical investigation & evaluation for antidiabetic activity of leafy extracts of various Ocimum (Tulsi) species by alloxan induced diabetic model. J Pharm Res 2011;4:28-9.
Borah R, Biswas SP. Tulsi (Ocimum sanctum), excellent source of phytochemicals. IJEAB. 2018;3(5):1732-8. doi: 10.22161/ijeab/3.5.21.
Blois MS. Antioxidant determinations by the use of a stable free radical. Nature 1958;5(4):181:1199-200. doi: 10.1038/1811199a.
- Authors retain copyright and grant the journal right of first publication with the work simultaneously licensed under a Creative Commons Attribution License that allows others to share the work with an acknowledgement of the work's authorship and initial publication in this journal.
- Authors are able to enter into separate, additional contractual arrangements for the non-exclusive distribution of the journal's published version of the work (e.g., post it to an institutional repository or publish it in a book), with an acknowledgement of its initial publication in this journal.
- Authors are permitted and encouraged to post their work online (e.g., in institutional repositories or on their website) prior to and during the submission process, as it can lead to productive exchanges, as well as earlier and greater citation of published work (See The Effect of Open Access).